Literature DB >> 8194252

Osteoarticular allografts to treat distal femoral osteonecrosis.

J M Flynn1, D S Springfield, H J Mankin.   

Abstract

Allografts, which are among the limited number of treatment options for young patients with large defects of the distal femur, offer a physiologic method of restoring knee function. Since 1980, 21 patients younger than 50 years old who had osteonecrosis involving large portions of the distal femur were treated with fresh-frozen osteoarticular surface replacements. This retrospective review evaluated the 15 patients (17 knees) whose follow-up time was greater than two years. The patients were reevaluated at regular intervals by one or more of the authors. Follow-up time ranged from two to nine years (mean, 4.2 years). Outcome was classified as either excellent, good (occasional complaints, unlimited walking without aids, functional range of motion), fair (intermittent pain, ambulatory tolerance limited), or failure. There were seven excellent results, five good results, one fair result, and four failures. There were no infections, nonunions, or wound complications. At this early follow-up period, 12 (70%) of the 17 knees have been successfully treated. The authors' success rate with frozen allografts is comparable to the results of fresh allograft resurfacing. Use of frozen allografts allows time for thorough testing for viral and bacterial infections, is more practical, and the allografts are available for use in elective surgery. Failure in this series was principally the result of degeneration of the allograft's articular cartilage, or fracture of the allograft.

Entities:  

Mesh:

Year:  1994        PMID: 8194252

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  14 in total

1.  Fresh osteochondral allografts for posttraumatic knee defects: long-term followup.

Authors:  A E Gross; W Kim; F Las Heras; D Backstein; O Safir; K P H Pritzker
Journal:  Clin Orthop Relat Res       Date:  2008-05-09       Impact factor: 4.176

2.  Fresh osteochondral allografting for steroid-associated osteonecrosis of the femoral condyles.

Authors:  Simon Görtz; Allison J De Young; William D Bugbee
Journal:  Clin Orthop Relat Res       Date:  2010-02-09       Impact factor: 4.176

3.  Use of large osteochondral allografts in reconstruction of traumatic uncontained distal femoral defects.

Authors:  Richard Fagan; Andrew J Furey
Journal:  J Orthop       Date:  2014-02-19

Review 4.  Osteonecrosis of the knee: review.

Authors:  Ammar R Karim; Jeffrey J Cherian; Julio J Jauregui; Todd Pierce; Michael A Mont
Journal:  Ann Transl Med       Date:  2015-01

5.  Osteoarticular and total elbow allograft reconstruction with severe bone loss.

Authors:  F Daniel Kharrazi; Benjamin T Busfield; Daniel S Khorshad; Francis J Hornicek; Henry J Mankin
Journal:  Clin Orthop Relat Res       Date:  2008-01-03       Impact factor: 4.176

Review 6.  Success rates and immunologic responses of autogenic, allogenic, and xenogenic treatments to repair articular cartilage defects.

Authors:  Christopher M Revell; Kyriacos A Athanasiou
Journal:  Tissue Eng Part B Rev       Date:  2009-03       Impact factor: 6.389

7.  Failures in bipolar fresh osteochondral allograft for the treatment of end-stage knee osteoarthritis.

Authors:  S Giannini; R Buda; A Ruffilli; G Pagliazzi; A Ensini; B Grigolo; G Desando; F Vannini
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-04-04       Impact factor: 4.342

8.  Use of fresh osteochondral allograft in repair of distal femur after trauma.

Authors:  Drew W Taylor; Kyle C Bohm; Jennifer E Taylor; Allan E Gross
Journal:  Mcgill J Med       Date:  2011-06

9.  Long term in-vivo studies of a photo-oxidized bovine osteochondral transplant in sheep.

Authors:  M K Akens; B von Rechenberg; P Bittmann; D Nadler; K Zlinszky; J A Auer
Journal:  BMC Musculoskelet Disord       Date:  2001-11-30       Impact factor: 2.362

10.  Medulloscopy-Assisted Surgery for Osteonecrosis of the Knee Following Treatment for Adolescent Leukemia: Mid-term Results.

Authors:  Eun Seok Choi; Hyun Dae Shin
Journal:  Indian J Orthop       Date:  2020-05-06       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.